Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone, Recombinant”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02217800
What this trial is testing

The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics

Who this might be right for
Acromegaly
Aspireo Pharmaceuticals Limited 8
Post-approval studies (Phase 4)Study completedNCT00519844
What this trial is testing

Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

Who this might be right for
Foetal Growth ProblemSmall for Gestational Age
Novo Nordisk A/S 5
Not applicableStudy completedNCT04938466
What this trial is testing

Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy

Who this might be right for
Growth Hormone DeficiencyGrowth Hormone Treatment
University of Minnesota 19
Not applicableStudy completedNCT01582334
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 68
Large-scale testing (Phase 3)Study completedNCT00123253
What this trial is testing

TH9507 in Patients With HIV-Associated Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
Theratechnologies 412
Testing effectiveness (Phase 2)Ended earlyNCT00684957
What this trial is testing

Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors

Who this might be right for
Growth Hormone Deficiency
Columbia University 5
Not applicableWithdrawnNCT04465565
What this trial is testing

Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test

Who this might be right for
Growth Hormone Deficiency
Rabin Medical Center
Not applicableStudy completedNCT01200875
What this trial is testing

Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

Who this might be right for
TendinopathyRheumatic Diseases
Stanford University 25
Not applicableActive Not RecruitingNCT05509894
What this trial is testing

Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone

Who this might be right for
Pediatric Growth Hormone Deficiency
Pfizer 565
Not applicableStudy completedNCT01080755
What this trial is testing

Metabolic Endocrinology and Growth Hormone in Adults

Who this might be right for
Adult Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany 90
Not applicableStudy completedNCT00646815
What this trial is testing

Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
University of Aarhus 24
Not applicableStudy completedNCT03525587
What this trial is testing

Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Azienda Ospedaliero-Universitaria di Modena 83
Post-approval studies (Phase 4)Study completedNCT01806298
What this trial is testing

An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)

Who this might be right for
Adult Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany 78
Post-approval studies (Phase 4)Study completedNCT02195947
What this trial is testing

Antagonist Protocol in Poor Responders

Who this might be right for
Female Infertility Due to Diminished Ovarian Reserve
Cairo University 141
Testing effectiveness (Phase 2)Study completedNCT00635960
What this trial is testing

Growth Hormone in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Federico II University 40
Large-scale testing (Phase 3)UnknownNCT01572259
What this trial is testing

Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism

Who this might be right for
Atherosclerotic Cardiovascular Disease
Assistance Publique Hopitaux De Marseille 40
Not applicableStudy completedNCT00006394
What this trial is testing

Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency

Who this might be right for
OsteoporosisGrowth Hormone Deficiency
National Center for Research Resources (NCRR) 72
Not applicableStudy completedNCT01075386
What this trial is testing

The Effects of the Endocrine System on Endometrial Cancer

Who this might be right for
Endometrial Cancer
Queensland Centre for Gynaecological Cancer 75
Post-approval studies (Phase 4)Study completedNCT01066052
What this trial is testing

Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

Who this might be right for
Turner's Syndrome
Merck KGaA, Darmstadt, Germany 115
Early research (Phase 1)UnknownNCT00473187
What this trial is testing

Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets

Who this might be right for
Hypophosphatemic RicketsGrowth DisordersSomatropin Therapy
University of Rostock
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation